By jurisdiction
Australia (TGA)
Every compound we track that has a recorded status under Australia (TGA). Tap a name for the full picture, including the U.S. status and primary sources.
| Compound | Status here | Note |
|---|---|---|
| BPC-157 | Restricted | Reported as Schedule 4 (prescription-only) under the Poisons Standard. |
| CJC-1295 | Restricted | Reported as Schedule 4 (prescription-only) under the Poisons Standard. |
| Ipamorelin | Restricted | Reported as Schedule 4 (prescription-only) under the Poisons Standard. |
| Melanotan II | Restricted | Schedule 4 (prescription-only); no products registered on the ARTG; TGA has issued infringement notices for unlawful supply. |
| NAD+ | Restricted | Per a TGA safety alert, NAD/NAD+/NADH are not permitted ingredients in listed medicines. |
| Semaglutide (compounded) | Restricted | GLP-1 analogues removed from the pharmacist compounding exemption effective Oct 1, 2024; remains Schedule 4. |
| Sermorelin | Restricted | Prescription-only (Schedule 4) as a GHRH analog; obtainable via compounding pharmacy on prescription. |
| TB-500 (Thymosin Beta-4) | Restricted | Thymosin beta-4 treated as Schedule 4 (prescription-only) under the Poisons Standard. |
| Thymosin Alpha-1 | Restricted | Regulated as Schedule 4 (prescription-only); the TGA has enforced against unlawful advertising. |
| Tirzepatide (compounded) | Restricted | GLP-1 compounding prohibited since Oct 1, 2024; remains Schedule 4. |
| GHK-Cu | Unscheduled | Not individually named in the Poisons Standard; topical cosmetic products are freely available. |
| Selank | Unscheduled | Not individually named or scheduled in the Poisons Standard. |
| Semax | Unscheduled | Not individually named in the Poisons Standard; sits in a grey area. |